Commonly used pain medications such as narcotics and over the counter pain medications are under influence of genetic make-up of individuals. A standard dose of a pain medication such as codeine may not be effective in one individual while the exact same dose may be toxic for another individual based on their genetic profile. Therefore, determining the genetic make-up of an individual can help with precision prescribing of the medications.
Opioids
| Medication | Gene |
| Codeine, Tramadol, Hydrocodone, Oxycodone, Oliceridine | CYP2D6 |
| Fentanyl, Buprenorphine, Oxycodone | CYP3A4, CYP3A5 |
| Methadone | CYP2B6 |
| Alfentanil, Sufentanil, Hydromorphone, Morphine, Fentanyl | OPRM1 |
Frequency of Cytochrome P450 (CYP2D6) Metabolizer Types in the population
| Cytochrome | Poor metabolizer | Intermediate metabolizer | Normal metabolizer | Rapid or ultra-rapid metabolizer |
| CYP2D6 | 4-7% | 9-35% | 50-90% | 2-3% |
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
| Medication | Gene |
| Ibuprofen, Piroxicam, Lornoxicam, Meloxicam, Flurbiprofen, Celecoxib, Diclofenac, Tenoxicam | CYP2C9 |
| Carisoprodol | CYP2C19 |
Frequency of Cytochrome P450 (CYP2D6 and CYP2C19) Metabolizer Types in the population
| Cytochrome | Poor metabolizer | Intermediate metabolizer | Normal metabolizer | Rapid or ultra-rapid metabolizer |
| CYP2C9 | 3% | 30% | 68% | N/A |
| CYP2C19 | 2-20% | 24-36% | 14-44% | 30% |
